[HTML][HTML] Treatment effects of the EGFR pathway drugs on head and neck cancer stem cells
GM de Mendonça Fernandes, VS Junior… - American Journal of …, 2022 - ncbi.nlm.nih.gov
Head and neck cancer (HNC) is the sixth most common cancer worldwide and show low
survival rates and drug resistance, which can be due to the presence of cancer stem cells …
survival rates and drug resistance, which can be due to the presence of cancer stem cells …
[PDF][PDF] Treatment effects of the EGFR pathway drugs on head and neck cancer stem cells
GM de Mendonça Fernandes, VS Junior… - researchgate.net
(1) Head and neck cancer (HNC) is the sixth most common cancer worldwide and show low
survival rates and drug resistance, which can be due to the presence of cancer stem cells …
survival rates and drug resistance, which can be due to the presence of cancer stem cells …
Treatment effects of the EGFR pathway drugs on head and neck cancer stem cells.
GMM Fernandes, ALS Galbiatti-Dias… - American Journal of …, 2022 - europepmc.org
Head and neck cancer (HNC) is the sixth most common cancer worldwide and show low
survival rates and drug resistance, which can be due to the presence of cancer stem cells …
survival rates and drug resistance, which can be due to the presence of cancer stem cells …
Original Treatment effects of the EGFR pathway drugs on head and neck cancer stem cells
GMM Fernandes, VS Junior… - AMERICAN JOURNAL …, 2022 - bv.fapesp.br
Head and neck cancer (HNC) is the sixth most common cancer worldwide and show low
survival rates and drug resistance, which can be due to the presence of cancer stem cells …
survival rates and drug resistance, which can be due to the presence of cancer stem cells …
[PDF][PDF] Treatment effects of the EGFR pathway drugs on head and neck cancer stem cells
GM de Mendonça Fernandes, VS Junior… - e-century.us
(1) Head and neck cancer (HNC) is the sixth most common cancer worldwide and show low
survival rates and drug resistance, which can be due to the presence of cancer stem cells …
survival rates and drug resistance, which can be due to the presence of cancer stem cells …
Treatment effects of the EGFR pathway drugs on head and neck cancer stem cells
GM de Mendonça Fernandes… - … journal of cancer …, 2022 - pubmed.ncbi.nlm.nih.gov
(1) Head and neck cancer (HNC) is the sixth most common cancer worldwide and show low
survival rates and drug resistance, which can be due to the presence of cancer stem cells …
survival rates and drug resistance, which can be due to the presence of cancer stem cells …
Treatment effects of the EGFR pathway drugs on head and neck cancer stem cells.
GMM Fernandes, ALS Galbiatti-Dias… - American Journal of …, 2022 - europepmc.org
(1) Head and neck cancer (HNC) is the sixth most common cancer worldwide and show low
survival rates and drug resistance, which can be due to the presence of cancer stem cells …
survival rates and drug resistance, which can be due to the presence of cancer stem cells …